Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Different bovine tissues show varying types of cytokeratins.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

SSEA-4 can distinguish between eccrine and apocrine sweat gland ducts.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Skin tumors and normal skin structures have different lectin-binding patterns.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Sheep with chronic Sarcoptes scabiei dermatitis have altered keratin expression in their skin.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.